European Archives - Page 991 of 1330 - European Medical Journal

Entering a New Era of Patient-Reported Outcomes in Inflammatory Bowel Disease: Past, Present, and Future

Considering patient-reported outcomes (PRO) for optimal disease management is pivotal in many chronic diseases, and inflammatory bowel disease (IBD) is…

EMJ Gastroenterology 7 [Suppl 2] 2018

This symposium took place on 16th February 2018 as part of the 13th Congress of the European Crohn’s and Colitis Organisation (ECCO) in Vienna, Austria

Individualised Care for Crohn's Disease: Evolving Approaches for a Progressive Disease

This symposium focusses on understanding the advantages and limitations of current management strategies for Crohn’s disease.

Routine Lung Check Enables Early Detection of Lung Cancer

A project in which people deemed to be at risk of poor lung health are invited to attend a routine lung health check has been highly…

Association Between Skin Cancer and the Risk of Other Malignancies

Basal cell carcinoma is one of the most common forms of skin cancer, with millions of Americans diagnosed with the malignancy each year. However…

Low Oxygen Concentration and Thrombosis

Hypoxia is commonly found in a number of disorders, including cancers, alcoholism, sickle cell anaemia, and nonalcoholic fatty liver disease. The oxygen…

New Scale Helps Match Patients to the Optimal Cancer Therapy

Targeted cancer treatment options should become more simplified and standardised following the creation of a new scale for tumour DNA mutations that has…

Gut Enzymes Could Make Any Blood Type Universally Available

Blood could become far more accessible following the discovery of a group of enzymes that are able to turn any type of blood into type O, which can be…

Early Detection of Vascular Diseases Can be Achieved Through Ultrasound Imaging

Vascular diseases can be detected before symptoms appear on ultrasound images of arteries, according to researchers from the University of…

Innovative Technique Can Predict Response to Lymphoma Therapy

Response to therapy in diffuse large B cell lymphoma patients can be assessed quickly by measuring changes in circulating tumour DNA (ctDNA) levels…